MICHAEL WEAVER: Open Payments
NPI 1760666366 · CHILLICOTHE, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$537 in 32 payments from 9 companies in 2025. Trend: 2023 $124 · 2024 $644 · 2025 $537
Food & beverage: $527Education: $10
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 14 | $194 |
| Ardelyx, Inc. | 3 | $56 |
| Gilead Sciences, Inc. | 3 | $55 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $55 |
| Phathom Pharmaceuticals, Inc. | 3 | $55 |
| ABBVIE INC. | 2 | $47 |
| Madrigal Pharmaceuticals | 2 | $39 |
| GENZYME CORPORATION | 1 | $25 |
| Janssen Pharmaceuticals, Inc | 1 | $10 |
Products named: TREMFYA, IBSRELA, VOQUEZNA, MAVYRET, REZDIFFRA, ENTYVIO, EOHILIA.
Industry payments across OH — which companies pay providers there.
